IRCT20110423006257N3
Recruiting
Phase 3
A clinical trial to evaluate the therapeutic effects of thalidomide in patients with COVID-19 infection
Overview
- Phase
- Phase 3
- Intervention
- Not specified
- Conditions
- Covid 19.
- Sponsor
- Arak University of Medical Sciences
- Enrollment
- 66
- Status
- Recruiting
- Last Updated
- 5 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Duration of the symptoms less than 10 days
- •Lymphocyte count less than 1000 per microliter
- •Quantitative CRP more than 1\.5 times normal
- •Positive pcr test of covid 19
- •O2 sat less than 93%
- •Respiratory rate less than 24
- •Chest CT scan findings compatible with COVID\-19 Pneumonia
Exclusion Criteria
- •History of chronic disease
- •Pregnant women, lactating women , sexually active premenopausal women
- •Loss of consciousness
- •Liver enzymes more than 5 times normal
Outcomes
Primary Outcomes
Not specified
Similar Trials
Active, not recruiting
Phase 2
Study on efficacy of herbal drugs in reducing viral load in HIV/AIDS patientsCTRI/2022/09/045548MVR Ayurveda medical college
Completed
Phase 2
A Clinical study on cervical spondylosis using thengaai thuruval ottradam (external therapy)Health Condition 1: M478- Other spondylosisCTRI/2021/02/031542Government Siddha medical college and hospital40
Recruiting
Not Applicable
Effect of trutyadi churna in amavata with special reference to rheumatoid arthritis.Health Condition 1: M049- Autoinflammatory syndrome, unspecifiedCTRI/2021/08/035463DR VISHNUPRIYA SEETHARAM
Not yet recruiting
Phase 3
Ayurvedic medicine-siddartakadi yoga in depressioHealth Condition 1: F320- Major depressive disorder, singleepisode, mildCTRI/2024/04/065341I
Not yet recruiting
Phase 3
Treatment protocol in Ayurveda for TINEAHealth Condition 1: B356- Tinea crurisCTRI/2022/11/047087Dr.BRKR GOVT Ayurvedic Medical college